News

MannKind saw decent growth from its two core products in Q2 and just signed a new non-dilutive financing agreement with ...
The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...
MannKind Corporation (MNKD) said on Wednesday that it has entered into up to $500 million strategic financing agreement with ...
(HealthDay News) — Intranasal administration of [ 68 Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23 in Alzheimer’s & Dementia: ...
Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...